From: Preferences for active and aggressive intervention among patients with advanced cancer
 | Chemo- Therapy N = 380 | Anti- biotics N = 380 | Anti- coagulants N = 380 | Blood transfusion N = 380 | Feeding tubes N = 380 | Artificial hydration N = 380 |
---|---|---|---|---|---|---|
Number (%) undecided about intervention | 89 (23.4) | 56 (14.7) | 51 (13.4) | 40 (10.5) | 15 (3.9) | 51 (13.4) |
Age | Â | Â | Â | Â | Â | Â |
Odds ratio: per 10 yr increase | 0.94 | 1.03 | 0.84 | 1.09 | 1.04 | 1.01 |
P-value | 0.512 | 0.784 | 0.148 | 0.542 | 0.865 | 0.917 |
Gender | Â | Â | Â | Â | Â | Â |
Odds ratio: Male vs. Female | 1.31 | 1.96 | 1.23 | 1.61 | 1.38 | 2.61 |
P-value | 0.347 | 0.054 | 0.563 | 0.248 | 0.588 | 0.011 |
Race | Â | Â | Â | Â | Â | Â |
Odds ratio: Non- vs. Caucasian | 0.75 | 1.77 | 1.46 | 1.81 | 1.67 | 2.44 |
P-value | 0.462 | 0.168 | 0.374 | 0.214 | 0.481 | 0.034 |
Cancer Diagnosis | Â | Â | Â | Â | Â | Â |
Odds ratio: | Â | Â | Â | Â | Â | Â |
   Lung vs. GI | 1.2 | 0.97 | 0.97 | 1.9 | 1.62 | 1.04 |
   GU vs. GI | 1.29 | 0.54 | 0.98 | 1.38 | 1.21 | 1.1 |
   Breast vs. GI | 1.1 | 1.62 | 0.85 | 2.07 | 0 | 1.72 |
   Hematologic vs. GI | 2.23 | 2.06 | 0.89 | 1.8 | 2.25 | 2.56 |
   GYN vs. GI | 3.26 | 2.36 | 1.89 | 3.16 | 1.39 | 2.37 |
   Other vs. GI | 1.56 | 0.65 | 0.59 | 0.49 | 1.49 | 0.56 |
P-value | 0.395 | 0.349 | 0.804 | 0.218 | 0.882 | 0.317 |
PPSv2 | Â | Â | Â | Â | Â | Â |
Odds ratio: per 10 unit increase | 0.91 | 1.01 | 0.77 | 0.99 | 1.07 | 0.83 |
P-value | 0.433 | 0.964 | 0.083 | 0.971 | 0.801 | 0.214 |
CCI | Â | Â | Â | Â | Â | Â |
Odds ratio: per unit increase | 0.92 | 0.89 | 0.9 | 0.96 | 0.83 | 0.9 |
P-value | 0.104 | 0.066 | 0.123 | 0.553 | 0.073 | 0.117 |
Decision maker | Â | Â | Â | Â | Â | Â |
Odds ratio: | Â | Â | Â | Â | Â | Â |
   Pat/SDM vs. Pat | 1.09 | 1.69 | 1.21 | 1.7 | 1.2 | 1.7 |
   SDM vs. Pat | 1.42 | 1.28 | 0.5 | 1.22 | 2.8 | 0.82 |
P-value | 0.701 | 0.445 | 0.137 | 0.504 | 0.498 | 0.177 |
Model P-value | 0.147 | 0.291 | 0.430 | 0.491 | 0.688 | 0.037 |